Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43155
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDevleesschauwer, B-
dc.contributor.authorWILLEM , Lander-
dc.contributor.authorJurcevic, J-
dc.contributor.authorSmith, P-
dc.contributor.authorScohy, A-
dc.contributor.authorWyper, GMA-
dc.contributor.authorPires, SM-
dc.contributor.authorVan Goethem, N-
dc.contributor.authorBeutels, P-
dc.contributor.authorFRANCO, Nicolas-
dc.contributor.authorABRAMS, Steven-
dc.contributor.authorVan Cauteren, D-
dc.contributor.authorSpeybroeck, N-
dc.contributor.authorHENS, Niel-
dc.contributor.authorDe Pauw, R-
dc.date.accessioned2024-06-14T11:07:09Z-
dc.date.available2024-06-14T11:07:09Z-
dc.date.issued2023-
dc.date.submitted2024-06-14T10:50:52Z-
dc.identifier.citationBMC PUBLIC HEALTH, 23 (1) (Art N° 1707)-
dc.identifier.urihttp://hdl.handle.net/1942/43155-
dc.description.abstractBurden of disease estimates have become important population health metrics over the past decade to measure losses in health. In Belgium, the disease burden caused by COVID-19 has not yet been estimated, although COVID-19 has emerged as one of the most important diseases. Therefore, the current study aims to estimate the direct COVID-19 burden in Belgium, observed despite policy interventions, during 2020 and 2021, and compare it to the burden from other causes.-
dc.description.sponsorshipFunding This study received funding from the European Union’s Horizon 2020 research and innovation programme - project EpiPose (Grant Agreement Number 101003688). This work refects only the authors’ view. The European Commission is not responsible for any use that may be made of the information it contains Acknowledgements This study was conducted within the framework of the Belgian National Burden of Disease Study (BeBOD), coordinated by Sciensano, the Belgian institute for health.-
dc.language.isoen-
dc.publisherBMC-
dc.rightsThe Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.-
dc.subject.otherBurden of disease-
dc.subject.otherCOVID-19-
dc.subject.otherDisability-adjusted life years-
dc.subject.otherYears of life lost-
dc.subject.otherYears lived with disability-
dc.titleThe direct disease burden of COVID-19 in Belgium in 2020 and 2021-
dc.typeJournal Contribution-
dc.identifier.issue1-
dc.identifier.volume23-
local.bibliographicCitation.jcatA1-
local.publisher.placeCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr1707-
dc.identifier.doi10.1186/s12889-023-16572-0-
dc.identifier.pmid37667264-
dc.identifier.isi001188313300001-
local.provider.typeWeb of Science-
local.uhasselt.internationalyes-
item.contributorDevleesschauwer, B-
item.contributorWILLEM , Lander-
item.contributorJurcevic, J-
item.contributorSmith, P-
item.contributorScohy, A-
item.contributorWyper, GMA-
item.contributorPires, SM-
item.contributorVan Goethem, N-
item.contributorBeutels, P-
item.contributorFRANCO, Nicolas-
item.contributorABRAMS, Steven-
item.contributorVan Cauteren, D-
item.contributorSpeybroeck, N-
item.contributorHENS, Niel-
item.contributorDe Pauw, R-
item.fullcitationDevleesschauwer, B; WILLEM , Lander; Jurcevic, J; Smith, P; Scohy, A; Wyper, GMA; Pires, SM; Van Goethem, N; Beutels, P; FRANCO, Nicolas; ABRAMS, Steven; Van Cauteren, D; Speybroeck, N; HENS, Niel & De Pauw, R (2023) The direct disease burden of COVID-19 in Belgium in 2020 and 2021. In: BMC PUBLIC HEALTH, 23 (1) (Art N° 1707).-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.eissn1471-2458-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
s12889-023-16572-0.pdfPublished version962.73 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.